ClinicalTrials.gg

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Sanaria Inc. clinical trials

Its pipeline, or its studies — you choose. Free with an account during the beta.

The registry lists 29 studies whose lead sponsor is Sanaria Inc. 4 are recruiting or about to start. Per ClinicalTrials.gov, last updated Nov 3, 2026.

Our grouping of 1 registry name, not the registry’s. See them and correct one ↓

Compare Sanaria with Novartis and GlaxoSmithKline →

Pipeline: 3 programs

Each counted once: 3 with a study Sanaria Inc. leads registered in the last two years.

  • Phase 1
  • Phase 2

The 3 programs — sign in to see the list, free: with every program, filter by condition or phase and sort by first study or primary completion.

“Registry” is the highest phase of Sanaria Inc.’s own registered studies; Sanaria Inc.’s own pipeline document is not read yet. “Primary completion” is the earliest date still ahead among its live studies when the main measure’s data collection ends, as the registry states it (most are estimates); results come later, if they are announced. Programs are read from ClinicalTrials.gov, joined across names by rules and decisions each recorded with its evidence.

What it is testing

The drugs Sanaria Inc.’s studies test, most studies first; none is open now — 1 drug with a page of their own. Each count opens the studies in search.

Studies, none open

Coming up

2 of Sanaria Inc.’s studies under way reach primary completion within a year. The dates are the sponsor’s own estimates, which often move.

Phase 3 Other phases

  1. N’26
  2. D
  3. J’27
  4. 1F
  5. M
  6. A
  7. M
  8. J
  9. J
  10. 1A
  11. S
  12. O
  13. N

Add all 2 to your calendar (.ics) → With an account.

All 29 at a glance

Where each study is in its life, its phase and its countries. Each count opens them in search.

  • Open now414%Recruiting 3 · Not yet recruiting 1
  • Completed2483%
  • Stopped early13%

Phase

  • Phase 123
  • Phase 27

Where

  • United States5
  • Tanzania4
  • Germany4
  • Netherlands3
  • Burkina Faso3
  • Equatorial Guinea3

Over the years

  1. 09
  2. 10
  3. 11
  4. 412
  5. 13
  6. 14
  7. 15
  8. 16
  9. 17
  10. 18
  11. 19
  12. 20
  13. 21
  14. 22
  15. 23
  16. 24
  17. 25
  18. 326

By the year each study started. 2026 so far in the lighter column.

Registry sponsor names on this page

Our grouping. This page groups the registry's lead sponsor names by company — our grouping, not the registry's. It can be wrong or incomplete: an acquired company whose name never mentions its owner may be missing. Use “Something wrong?” under any name below to correct it.

Tell us about a missing company
No account needed. Please leave out personal details.

Each name exactly as ClinicalTrials.gov lists it, and how it relates to Sanaria Inc.

  • Sanaria Inc.
    Same company
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    29 studies

Focus areas

Conditions Sanaria Inc. leads ten or more studies in, by study count. A broader condition is left out when almost all its studies are already in a narrower one listed here.

Studies

Recruiting first, then most recently updated. Showing 29 of 29.